Global Heart Failure Drugs Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Heart Failure Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Heart Failure Drugs Market Size Growth Rate by Type
  • 1.4.2 ACEI
  • 1.4.3 Angiotensin II Receptor Blockers
  • 1.2.4 ARNIs
  • 1.2.5 Beta Blockers
  • 1.2.6 Aldosterone Antagonists
  • 1.2.7 Diuretics
• 1.3 Market by Application
  • 1.3.1 Global Heart Failure Drugs Market Size Growth Rate by Application
  • 1.3.2 Reduced Ejection Fraction
  • 1.3.3 Preserved Ejection Fraction
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Heart Failure Drugs Sales Estimates and Forecasts 2016-2027
• 2.2 Global Heart Failure Drugs Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Heart Failure Drugs Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Heart Failure Drugs Regions by Sales
  • 2.4.1 Global Top Heart Failure Drugs Regions by Sales (2016-2021)
  • 2.4.2 Global Top Heart Failure Drugs Regions by Sales (2022-2027)
• 2.5 Global Top Heart Failure Drugs Regions by Revenue
  • 2.5.1 Global Top Heart Failure Drugs Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Heart Failure Drugs Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Heart Failure Drugs Sales by Manufacturers
  • 3.1.1 Global Top Heart Failure Drugs Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Heart Failure Drugs Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Heart Failure Drugs Sales in 2020
• 3.2 Global Heart Failure Drugs Revenue by Manufacturers
  • 3.2.1 Global Top Heart Failure Drugs Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Heart Failure Drugs Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Heart Failure Drugs Revenue in 2020
• 3.3 Global Heart Failure Drugs Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Heart Failure Drugs Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Heart Failure Drugs Sales by Type
  • 4.1.1 Global Heart Failure Drugs Historical Sales by Type (2016-2021)
  • 4.1.2 Global Heart Failure Drugs Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Heart Failure Drugs Sales Market Share by Type (2016-2027)
• 4.2 Global Heart Failure Drugs Revenue by Type
  • 4.2.1 Global Heart Failure Drugs Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Heart Failure Drugs Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Heart Failure Drugs Revenue Market Share by Type (2016-2027)
• 4.3 Global Heart Failure Drugs Price by Type
  • 4.3.1 Global Heart Failure Drugs Price by Type (2016-2021)
  • 4.3.2 Global Heart Failure Drugs Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Heart Failure Drugs Sales by Application
  • 5.1.1 Global Heart Failure Drugs Historical Sales by Application (2016-2021)
  • 5.1.2 Global Heart Failure Drugs Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Heart Failure Drugs Sales Market Share by Application (2016-2027)
• 5.2 Global Heart Failure Drugs Revenue by Application
  • 5.2.1 Global Heart Failure Drugs Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Heart Failure Drugs Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Heart Failure Drugs Revenue Market Share by Application (2016-2027)
• 5.3 Global Heart Failure Drugs Price by Application
  • 5.3.1 Global Heart Failure Drugs Price by Application (2016-2021)
  • 5.3.2 Global Heart Failure Drugs Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Heart Failure Drugs Market Size by Type
  • 6.1.1 North America Heart Failure Drugs Sales by Type (2016-2027)
  • 6.1.2 North America Heart Failure Drugs Revenue by Type (2016-2027)
• 6.2 North America Heart Failure Drugs Market Size by Application
  • 6.2.1 North America Heart Failure Drugs Sales by Application (2016-2027)
  • 6.2.2 North America Heart Failure Drugs Revenue by Application (2016-2027)
• 6.3 North America Heart Failure Drugs Market Size by Country
  • 6.3.1 North America Heart Failure Drugs Sales by Country (2016-2027)
  • 6.3.2 North America Heart Failure Drugs Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Heart Failure Drugs Market Size by Type
  • 7.1.1 Europe Heart Failure Drugs Sales by Type (2017-2027)
  • 7.1.2 Europe Heart Failure Drugs Revenue by Type (2017-2027)
• 7.2 Europe Heart Failure Drugs Market Size by Application
  • 7.2.1 Europe Heart Failure Drugs Sales by Application (2017-2027)
  • 7.2.2 Europe Heart Failure Drugs Revenue by Application (2017-2027)
• 7.3 Europe Heart Failure Drugs Market Size by Country
  • 7.3.1 Europe Heart Failure Drugs Sales by Country (2017-2027)
  • 7.3.2 Europe Heart Failure Drugs Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Heart Failure Drugs Market Size by Type
  • 8.1.1 Asia Pacific Heart Failure Drugs Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Heart Failure Drugs Revenue by Type (2018-2027)
• 8.2 Asia Pacific Heart Failure Drugs Market Size by Application
  • 8.2.1 Asia Pacific Heart Failure Drugs Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Heart Failure Drugs Revenue by Application (2018-2027)
• 8.3 Asia Pacific Heart Failure Drugs Market Size by Region
  • 8.3.1 Asia Pacific Heart Failure Drugs Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Heart Failure Drugs Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Heart Failure Drugs Market Size by Type
  • 9.1.1 Latin America Heart Failure Drugs Sales by Type (2019-2027)
  • 9.1.2 Latin America Heart Failure Drugs Revenue by Type (2019-2027)
• 9.2 Latin America Heart Failure Drugs Market Size by Application
  • 9.2.1 Latin America Heart Failure Drugs Sales by Application (2019-2027)
  • 9.2.2 Latin America Heart Failure Drugs Revenue by Application (2019-2027)
• 9.3 Latin America Heart Failure Drugs Market Size by Country
  • 9.3.1 Latin America Heart Failure Drugs Sales by Country (2019-2027)
  • 9.3.2 Latin America Heart Failure Drugs Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Heart Failure Drugs Market Size by Type
  • 6.1.1 Middle East and Africa Heart Failure Drugs Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Heart Failure Drugs Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Heart Failure Drugs Market Size by Application
  • 6.2.1 Middle East and Africa Heart Failure Drugs Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Heart Failure Drugs Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Heart Failure Drugs Market Size by Country
  • 6.3.1 Middle East and Africa Heart Failure Drugs Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Heart Failure Drugs Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 Novartis
  • 11.1.1 Novartis Corporation Information
  • 11.1.2 Novartis Overview
  • 11.1.3 Novartis Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Novartis Heart Failure Drugs Product Description
  • 11.1.5 Novartis Related Developments
• 11.2 Pfizer
  • 11.2.1 Pfizer Corporation Information
  • 11.2.2 Pfizer Overview
  • 11.2.3 Pfizer Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Pfizer Heart Failure Drugs Product Description
  • 11.2.5 Pfizer Related Developments
• 11.3 AstraZeneca
  • 11.3.1 AstraZeneca Corporation Information
  • 11.3.2 AstraZeneca Overview
  • 11.3.3 AstraZeneca Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 AstraZeneca Heart Failure Drugs Product Description
  • 11.3.5 AstraZeneca Related Developments
• 11.4 Hikma
  • 11.4.1 Hikma Corporation Information
  • 11.4.2 Hikma Overview
  • 11.4.3 Hikma Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Hikma Heart Failure Drugs Product Description
  • 11.4.5 Hikma Related Developments
• 11.5 Teva
  • 11.5.1 Teva Corporation Information
  • 11.5.2 Teva Overview
  • 11.5.3 Teva Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Teva Heart Failure Drugs Product Description
  • 11.5.5 Teva Related Developments
• 11.6 Cipla
  • 11.6.1 Cipla Corporation Information
  • 11.6.2 Cipla Overview
  • 11.6.3 Cipla Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Cipla Heart Failure Drugs Product Description
  • 11.6.5 Cipla Related Developments
• 11.7 Merck & Co.
  • 11.7.1 Merck & Co. Corporation Information
  • 11.7.2 Merck & Co. Overview
  • 11.7.3 Merck & Co. Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Merck & Co. Heart Failure Drugs Product Description
  • 11.7.5 Merck & Co. Related Developments
• 11.8 Amgen
  • 11.8.1 Amgen Corporation Information
  • 11.8.2 Amgen Overview
  • 11.8.3 Amgen Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Amgen Heart Failure Drugs Product Description
  • 11.8.5 Amgen Related Developments
• 11.9 Roche
  • 11.9.1 Roche Corporation Information
  • 11.9.2 Roche Overview
  • 11.9.3 Roche Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Roche Heart Failure Drugs Product Description
  • 11.9.5 Roche Related Developments
• 11.10 Sun Pharma
  • 11.10.1 Sun Pharma Corporation Information
  • 11.10.2 Sun Pharma Overview
  • 11.10.3 Sun Pharma Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Sun Pharma Heart Failure Drugs Product Description
  • 11.10.5 Sun Pharma Related Developments
• 11.1 Novartis
  • 11.1.1 Novartis Corporation Information
  • 11.1.2 Novartis Overview
  • 11.1.3 Novartis Heart Failure Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Novartis Heart Failure Drugs Product Description
  • 11.1.5 Novartis Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Heart Failure Drugs Value Chain Analysis
• 12.2 Heart Failure Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Heart Failure Drugs Production Mode & Process
• 12.4 Heart Failure Drugs Sales and Marketing
  • 12.4.1 Heart Failure Drugs Sales Channels
  • 12.4.2 Heart Failure Drugs Distributors
• 12.5 Heart Failure Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Heart Failure Drugs Industry Trends
• 13.2 Heart Failure Drugs Market Drivers
• 13.3 Heart Failure Drugs Market Challenges
• 13.4 Heart Failure Drugs Market Restraints

14 Key Findings in The Global Heart Failure Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details